Oobli

Investment Climate Podcast

© Investment Climate Podcast
Investments & Finance

Investment Climate Podcast: Ali Wing of Oobli, How to Get Funded in 2025

In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2025 and uncovers the investment playbooks of successful Climate Tech CEOs and Leading VCs. Podcast Host Alex Shandrovksy is a strategic advisor to numerous global food tech accelerators and companies, including alternative proteins and cellular agriculture leaders. His focus is on investor relations and post-raise scale for agrifood tech companies. This podcast is syndicated through our media partners; Foodtech Weekly and Vegconomist. Episode 22: Oobli In this episode, I sat down with Ali Wing, CEO of Oobli, to explore how sweet proteins are revolutionizing the way we think about sugar reduction in food. Ali takes us through Oobli’s Series B1 fundraising journey, the importance of regulatory approvals, and how they …

more

Oobli

© Oobli
Fermentation

Ingredion Joins Forces with Oobli to Expand Access to Next-Gen Sweet Protein Solutions

Oobli, a biotechnology company specializing in sweet proteins, has announced a partnership with global ingredient solutions provider Ingredion. The collaboration aims to expand industry access to alternative sweetener systems by integrating Oobli’s sweet proteins with Ingredion’s portfolio, including stevia. Sweet proteins, derived from natural sources and produced through precision fermentation, offer a low-calorie alternative to traditional sweeteners. These proteins can be used in a variety of food and beverage applications, including sodas, baked goods, yogurts, and confectionery, either as standalone ingredients or in combination with other sweeteners. Ingredion, which has been actively expanding its sugar reduction solutions, views sweet proteins as a complementary addition to its existing product lines. Nate Yates, VP and GM of sugar reduction and fiber fortification at Ingredion, said, “We’ve long …

more

© Oobli
Fermentation

Oobli Gains FDA Nod for Sweet Protein Monellin, Expands Portfolio of Zero Glycemic Impact Sweeteners

US sweet protein developer Oobli (formerly Joywell Foods) announces that it has received the FDA’s first “no questions” letter for its monellin sweet protein, produced via precision fermentation. With the letter, the FDA confirmed that Oobli’s monellin is safe to use as a sweetener in food and beverages. The acknowledgment follows a previous FDA approval of brazzein, another sweet-tasting protein. Monellin is originally found in the serendipity berry of the Dioscoreophyllum cumminsii plant, and brazzein is in the fruit of the Oubli plant. Both scarce sweet proteins are said to be significantly sweeter than sugar. Founder and CTO Jason Ryder shared, “Having additional sweet proteins on the Oobli platform will enable companies across the globe to focus on ways to reduce sugar without compromising taste. …

more

Oobli and Grupo Bimbo have partnered to incorporate sweet proteins into baked goods.

© Oobli
Fermentation

Oobli’s Microbial Proteins to Sweeten Bimbo’s Baked Goods in a “Completely New Way”

California’s Oobli has partnered with Grupo Bimbo, a Mexican multinational food company touted as the largest bakery company in the United States and with a presence in 33+ countries, to introduce into baked goods its ultra-sweet proteins made with precision fermentation. This collaboration marks Oobli’s first global CPG partnership and Grupo Bimbo’s first time testing sweet proteins in products. Bimbo owns Oroweat, New York Bakery Co., and Entenmann’s, among other brands.  Oobli’s novel microbial proteins, which recently achieved GRAS (Generally Recognized as Safe) status, are described as natural sweeteners that, unlike traditional sugar, do not lead to diabetes, obesity, or sugar cravings because they are digested as protein rather than carbohydrates.  Ali Wing, CEO of Oobli, commented, “Sweet proteins have the potential to revolutionize sweetness and are a completely new way to think about how we …

more

Oobli, a Sweet protein developer from California, formerly Joywell Foods, has received what it claims to be the FDA's first "No questions" letter for a brazzein protein made with precision fermentation.

© Oobli
Fermentation

Oobli Receives FDA No Questions Letter for Oubli Fruit Sweet Protein Made with Precision Fermention

Oobli, formerly Joywell Foods, a sweet protein developer from California, USA, announces that it has received what it claims to be the FDA’s first “No questions” letter for its brazzein protein made with precision fermentation. The US Food and Drug Administration letter confirms Oobli’s self-affirmed GRAS (generally recognized as safe) status for Oubli Fruit Sweet Protein and supports its use as a food and beverage ingredient in the USA. Ali Wing, CEO of Oobli, shares, “The “No questions” letter from the FDA is a further testament to the strong potential that sweet proteins have to disrupt our global dependence on sugar and alternative sweeteners. The Oubli Fruit Sweet Protein can be safely used in various foods with support from the general scientific community and the …

more